Every day, 1,000 young women and girls get HIV, 4,000 lives are lost to TB, and millions who could be helped suffer from serious mental illnesses. Johnson & Johnson’s efforts in tackling these health threats, alongside many others, is why the company has continued to rank among the top three working to expand global access to medicines in low- and middle-income countries according to the Access to Medicine Index (ATMI).
![hqdefault.jpg](https://jnj-content-lab2.brightspotcdn.com/dims4/default/ae7b0f0/2147483647/strip/true/crop/480x270+0+45/resize/1440x810!/quality/90/?url=https%3A%2F%2Fi.ytimg.com%2Fvi%2Ffj-V7tAirPc%2Fhqdefault.jpg)